Table 4 |
||||||
|
Lipid panel, glucose and selected markers of fuel status and utilization for the high energy, high carbohydrate diet + exercise (HED; 2,600: 55:15:30), no diet + exercise (ND), very low carbohydrate, high protein diet + exercise (VLCHP: 1,200; 63:7:30), low carbohydrate, moderate protein diet + exercise (LCMP: 1,200; 50:20:30), high carbohydrate, low protein diet + exercise (HCLP: 1,200; 55:15:30). |
||||||
|
P-value |
||||||
|
|
||||||
|
Variable |
Group |
Week 0 |
Week 10 |
Week 14 |
Within Group |
G × T |
|
|
||||||
|
Total Cholesterol (mmol•L-1) |
HED |
5.2 ± 1.0 |
4.8 ± 0.9* |
5.1 ± 1.3 |
0.12 |
0.67 |
|
ND |
5.4 ± 1.0 |
5.1 ± 1.5 |
5.0 ± 1.0 |
0.33 |
||
|
VLCHP |
5.2 ± 1.0 |
5.2 ± 1.1 |
5.1 ± 1.2 |
0.84 |
||
|
LCMP |
4.9 ± 1.0 |
4.7 ± 0.9 |
5.0 ± 0.7 |
0.11 |
||
|
HCLP |
4.9 ± 0.9 |
4.6 ± 0.9 |
4.7 ± 0.8 |
0.11 |
||
|
CON |
5.1 ± 1.1 |
4.6 ± 1.1 |
4.9 ± 1.1 |
< 0.01 |
||
|
|
||||||
|
HDL Cholesterol (mmol•L-1) |
HED |
1.4 ± 0.3 |
1.3 ± 0.2 |
1.4 ± 0.2 |
0.16 |
0.90 |
|
ND |
1.3 ± 0.2 |
1.3 ± 0.2 |
1.3 ± 0.2 |
0.55 |
||
|
VLCHP |
1.3 ± 0.4 |
1.3 ± 0.3 |
1.3 ± 0.4 |
0.94 |
||
|
LCMP |
1.4 ± 0.4 |
1.3 ± 0.3 |
1.4 ± 0.3 |
0.18 |
||
|
HCLP |
1.3 ± 0.2 |
1.3 ± 0.3 |
1.3 ± 0.3 |
0.86 |
||
|
CON |
1.2 ± 0.3 |
1.2 ± 0.2 |
1.2 ± 0.3 |
0.81 |
||
|
|
||||||
|
LDL Cholesterol (mmol•L-1) |
HED |
3.2 ± 0.9 |
2.9 ± 0.7 |
3.2 ± 1.1 |
0.10 |
0.63 |
|
ND |
3.5 ± 1.1 |
3.3 ± 1.6 |
3.3 ± 1.2 |
0.55 |
||
|
VLCHP |
3.1 ± 0.8 |
3.2 ± 0.9 |
3.1 ± 1.0 |
0.97 |
||
|
LCMP |
2.8 ± 0.7 |
2.7 ± 0.7 |
2.9 ± 0.6 |
0.16 |
||
|
HCLP |
3.0 ± 0.7 |
2.8 ± 0.8 |
2.9 ± 0.7 |
0.28 |
||
|
CON |
3.2 ± 0.9 |
2.8 ± 1.0 |
3.0 ± 0.8 |
0.07 |
||
|
|
||||||
|
Triglycerides (mmol•L-1) |
HED |
1.2 ± 0.5 |
1.2 ± 0.4 |
1.2 ± 0.6 |
0.89 |
0.95 |
|
ND |
1.4 ± 0.3 |
1.0 ± 0.3* |
1.0 ± 0.2 |
0.07 |
||
|
VLCHP |
1.6 ± 0.7 |
1.4 ± 0.9 |
1.5 ± 0.9 |
0.09 |
||
|
LCMP |
1.4 ± 0.7 |
1.3 ± 0.6 |
1.3 ± 0.5 |
0.10 |
||
|
HCLP |
1.3 ± 0.6 |
1.2 ± 0.5* |
1.2 ± 0.5 |
< 0.05 |
||
|
CON |
1.5 ± 0.7 |
1.3 ± 0.8 |
1.5 ± 0.9 |
0.80 |
||
|
|
||||||
|
Insulin (pmol•L-1) |
HED |
252 ± 333 |
211 ± 312 |
206 ± 313 |
0.08 |
0.46 |
|
ND |
60 ± 50 |
53 ± 46 |
154 ± 226 |
0.43 |
||
|
VLCHP |
351 ± 377 |
292 ± 341* |
294 ± 325*b |
< 0.005 |
||
|
LCMP |
274 ± 410 |
233 ± 392 |
245 ± 398 |
0.23 |
||
|
HCLP |
227 ± 19 |
187 ± 200 |
200 ± 218 |
0.13 |
||
|
CON |
||||||
|
|
||||||
|
Glucose (mmol•L-1) |
HED |
5.5 ± 0.5 |
5.8 ± 0.5 |
5.6 ± 0.5 |
0.20 |
0.85 |
|
ND |
5.2 ± 0.5 |
5.3 ± 1.3 |
5.1 ± 0.5 |
0.86 |
||
|
VLCHP |
5.5 ± 1.3 |
5.7 ± 1.9 |
5.6 ± 1.9 |
0.33 |
||
|
LCMP |
5.4 ± 1.0 |
5.4 ± 0.6 |
5.3 ± 0.6 |
0.39 |
||
|
HCLP |
5.4 ± 0.8 |
5.4 ± 0.6 |
5.2 ± 0.6 |
< 0.05 |
||
|
CON |
5.1 ± 0.6 |
5.0 ± 0.6 |
4.9 ± 0.9 |
0.75 |
||
|
|
||||||
|
HOMA-IR |
HED |
9.5 ± 13.7 |
8.1 ± 11.9 |
7.3 ± 10.6 |
0.11 |
0.55 |
|
ND |
2.0 ± 1.6 |
1.7 ± 1.3 |
5.3 ± 7.8 |
0.42 |
||
|
VLCHP |
12.5 ± 13.4 |
10.9 ± 12.5 |
10.5 ± 11.6* b |
< 0.05 |
||
|
LCMP |
9.3 ± 12.9 |
8.0 ± 12.6 |
7.8 ± 10.9 |
0.21 |
||
|
HCLP |
8.1 ± 7.4 |
6.6 ± 7.4 |
6.8 ± 7.6 |
0.11 |
||
|
CON |
||||||
|
|
||||||
|
Leptin (pg•mL-1) |
HED |
21.2 ± 6.4 |
19.4 ± 4.0 |
18.6 ± 5.9 |
0.33 |
< 0.05 |
|
ND |
20.1 ± 6.8 |
15.4 ± 8.8 |
19.1 ± 7.9 |
0.18 |
||
|
VLCHP |
23.0 ± 7.5 |
17.1 ± 7.4* |
18.0 ± 7.2* |
< 0.001 |
||
|
LCMP |
22.8 ± 7.9 |
21.8 ± 8.3 |
20.1 ± 7.8* |
< 0.05 |
||
|
HCLP |
21.2 ± 7.0 |
17.8 ± 7.0* |
17.8 ± 7.7* |
< 0.001 |
||
|
CON |
||||||
|
|
||||||
|
Ketones (uM) |
HED |
0.06 ± 0.04 |
0.06 ± 0.04 |
0.16 ± 0.25 |
0.23 |
< 0.05 |
|
ND |
0.18 ± 0.15 |
0.21 ± 0.15 |
0.37 ± 0.64 |
0.50 |
||
|
VLCHP |
0.09 ± 0.09 |
0.14 ± 0.19 |
0.08 ± 0.06 |
0.13 |
||
|
LCMP |
0.10 ± 0.13 |
0.10 ± 0.11 |
0.07 ± 0.05 |
0.34 |
||
|
HCLP |
0.08 ± 0.06 |
0.10 ± 0.07 |
0.07 ± 0.05 |
0.06 |
||
|
CON |
||||||
|
|
||||||
|
Cortisol (nmol•L-1) |
HED |
1051 ± 878 |
1049 ± 692 |
833 ± 353 |
0.48 |
0.75 |
|
ND |
982 ± 556 |
1039 ± 485 |
855 ± 366 |
0.53 |
||
|
VLCHP |
921 ± 462 |
1011 ± 557 |
954 ± 439b, e |
0.37 |
||
|
LCMP |
957 ± 405 |
939 ± 370 |
914 ± 413b, e |
0.79 |
||
|
HCLP |
986 ± 447 |
949 ± 446 |
945 ± 487b |
0.82 |
||
|
CON |
||||||
|
|
||||||
|
Dietary intake is presented as calorie intake: % carbohydrate: protein: fat. All data is presented as group means ± standard deviation for week 0, week 10 and week 14. Individual main effects for time are provided as within-group P-values. Group × time interaction effects are provided as G × T P-values. Between-group significance indicators represent the delta change from baseline at week 14. Significance level was 0.05. NOTE: Insulin, HOMA-IR, leptin, ketones and cortisol were not run on the CON group due to an inability to collect an appropriate numbers of samples. *Different from baseline, P < 0.05, bDifferent from ND, P < 0.05, eDifferent from HED, P < 0.05. |
||||||
|
Kerksick et al. Nutrition Journal 2010 9:59 doi:10.1186/1475-2891-9-59 |
||||||